Abstract
Wernicke described the clinical features of three patients, including two alcoholics, suffering from confusion, ataxia and ophthalmoplegia in whom pathologically he found ‘polioencephalitis haemorrhagica superioris’. Korsakoff’s doctoral thesis related similar findings but expanded the confabulation and amnesic elements, relating them to alcoholism. This paper, which summarises the salient aspects of the syndrome, discusses their work and shows important earlier descriptions by James Jackson, (1822) Samuel Wilks (1868) and Charles Gayet (1875).
References
1.
McHenry LC: Garrison’s History of Neurology. Springfield, Thomas, 1969, pp 358–364.
2.
Wernicke C: Der aphasische Symptomencomplex. Breslau, Taschen, 1874.
3.
Wernicke K: Die akute, hämorrhagische Polioencephalitis superior. Lehrbuch der Gehirnkrankheiten. Kassel, Fischer, 1881, vol 2, pp 229–242.
4.
Huss M: Alcoholismus chronicus eller kronisk alkoholsjukdom (2 parts). Stockholm, 1849, 1851. German transl by von Dem Busch G, Leipzig, 1852.
5.
Korsakoff SS: Ob alkogol’nom paraliche (Of alcoholic paralysis: disturbance of psychic activity and its relation to the disturbance of the psychic sphere in multiple neuritis of nonalcoholic origin). Vestnick Klin Psychiat Neurol 1887;4:1–102. Ezhened Klin Gaz 1889;9:85, 115, 136. Engl transl Neurology 1955;5:395–406.
6.
Jackson J: On a peculiar disease resulting from the use of ardent spirits. New Engl J Med 1822;2:351–353. http://www.whonamedit.com/synd.cfm/930.html.
7.
Wilks S: Alcoholic paraplegia. Med Times Gaz 1868;2:467–472.
8.
Gayet CJA: Affection encéphalique (encéphalite diffuse probable): localisée aux étages supérieurs des pédoncles cérébraux et aux couches optiques, ainsi qu’au plancher du quatrième ventricule et aux parois laterales du troisième – Observation recueillie. Arch Physiol Normale Pathol 1875;2:341–351. http://web2.bium.univ-paris5.fr/livanc/?p=1&cote=epo0998&do=page.
9.
Victor M, Adams RD, Collins GH: The Wernicke-Korsakoff Syndrome. A Clinical and Pathological Study of 245 Patients, 82 with Post-Mortem Examinations. Philadelphia, Davis, 1971.
10.
Harper CG, Giles M, Finlay-Jones R: Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy. J Neurol Neurosurg Psychiatry 1986;49:341–345.
11.
Caine D, Halliday GM, Kril JJ, Harper CG: Operational criteria for the classification of chronic alcoholics: identification of Wernicke’s encephalopathy. J Neurol Neurosurg Psychiatry 1997;62:51–60.
12.
Bae SJ, Lee HK, Lee JH, Choi CG, Suh DC: Wernicke’s encephalopathy: atypical manifestation at MR imaging. Am J Neuroradiol 2001;22:1480–1482.
13.
Cook CCH, Hallwood PM, Thomson AD: B-vitamin deficiency and neuro-psychiatric syndromes in alcohol misuse. Alcohol Alcohol 1998;33:317–336.
14.
Blansjaar BA, Van Dijk JG: Korsakoff-Wernicke syndrome. Alcohol Alcohol 1992;27:435–437.
15.
Butterworth R: Effects of thiamine deficiency on brain metabolism: implications for the pathogenesis of Wernicke-Korsakoff syndrome. Alcohol Alcohol 1989;24:271–279.
16.
Todd KG, Hazell AS, Butterworth RF: Alcohol-thiamine interactions: an update on the pathogenesis of Wernicke encephalopathy. Addict Biol 1999;4:261–272.
17.
Buscaglia J, Faris J: Unsteady, unfocused, and unable to hear. Am J Med 2005;118:1215–1217.
18.
Thomson AD, Cook CC, Touquet R, et al: The Royal College of Physicians report on alcohol: guidelines for managing Wernicke’s encephalopathy in the accident and emergency department. Alcohol Alcohol 2002;37:513–521.
19.
Victor MV, Adams RC, Collins GH: The Wernicke-Korsakoff Syndrome and Related Neurologic Disorders Due to Alcoholism and Malnutrition. Philadelphia, Davis, 1989.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
